Is ZYNTEGLO right for your patient?
≥12 years of age who do not have a β0/β0 genotype and who do not have an HLA-matched related donor.1
CONSIDER TREATMENT FOR PATIENTS WHO MEET THESE CRITERIA1:
Diagnosed with TDT
Who do not have a β0/β0 genotype
Patients ≥12 years of age
Appropriate for haematopoietic stem cell transplant (HSCT)
No human leukocyte antigen (HLA)–matched related haematopoietic stem cell donor available
- Hypersensitivity to the active substance or to any of the excipients
- Pregnancy and breastfeeding
- Previous treatment with HSC gene therapy
- Contraindications to the mobilisation agents and the myeloablative conditioning agent must be considered
Please consult the full Summary of Product Characteristics (SmPC) and the Prescribing Information (PI) before prescribing.